@article{article, title  = {{TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancer.}},

 publisher = {{NIHR Health Technology Assessment Programme}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/104845 http://dx.doi.org/10.3310/hta20530 }},

 year = {{2016}},

 month = {{7}},

 author = {{James N and Pirrie S and Pope A and Barton D and Andronis L and Goranitis I and Collins S and McLaren D and O'Sullivan J and Parker C and Porfiri E et al}},

 doi = {{10.3310/hta20530}},

 volume = {{20}},

 journal = {{Health Technology Assessment}},

 note = {{Accessed on 2025/12/05}}}